ODYSSEY Outcomes trial

Study / Research

A cardiovascular outcomes trial that tested PCSK9 inhibitors, showing a reduction in cardiovascular events.

Mentioned in 1 video

Videos Mentioning ODYSSEY Outcomes trial

210 - Lp(a) and its impact on heart disease | Benoît Arsenault, Ph.D.& Peter Attia, M.D.

210 - Lp(a) and its impact on heart disease | Benoît Arsenault, Ph.D.& Peter Attia, M.D.

Peter Attia MD

A cardiovascular outcomes trial that tested PCSK9 inhibitors, showing a reduction in cardiovascular events.